Mesothelioma Growth Slowed by Curcumin and Peptides

Study Finds Mesothelioma Growth Slowed by Curcumin and Peptides, According to Surviving Mesothelioma Cancer researchers in Ohio and Germany have demonstrated that mesothelioma cells can be destroyed in the lab with a combination of components, one of which comes from a popular spice. Raleigh, NC – September 26 –  New research appears to support the cancer-fighting power of curcumin, a polyphenol that is the primary component in the Asian spice, turmeric. Surviving Mesothelioma has just posted the full story on its website. Click here to read it now. Doctors at the Case Comprehensive Cancer Center in Ohio and the Georg-Speyer-Haus Institute for Biomedical Research in Germany treated mesothelioma cells with a combination of curcumin and peptides extracted from PIAS3, a molecule shown to neutralize a cancer-triggering protein. “Our interest for the future is that we want to find better, more simple ways to increase intracellular levels of PIAS3 for malign ant mesothelioma through the use of synthetic PIAS3 peptide or curcumin analogs,” says Dr. Afshin Dowlati, a professor at Case Western Reserve School of Medicine. With the help of curcumin, PIAS3 neutralized the effects of STAT3, a signaling protein linked to the start and growth of mesothelioma and other cancers. The findings appear in Clinical Cancer Research. “These findings add to the growing body of research suggesting that this simple spice could hold important clues about how we can better combat mesothelioma and other intractable cancers,” says Alex Strauss, Managing Editor of Surviving Mesothelioma. To learn more about curcumin and its links to cancer, see Component in Spice May Help Slow Mesothelioma Growth, now available on the Surviving Mesothelioma website. Dabir, S et al, “Low PIAS3 Expression in Malignant mesothelioma is associated with increased STAT3 activation and poor patient survival”, August 14, 2014, Clinical Cancer Research, Epub ahead of print, For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions. Contact Information Michael Ellis Cancer Monthy +1 (919) 570-8595

Posted in News | Comments Off on Mesothelioma Growth Slowed by Curcumin and Peptides

New Medical Radiation Treatment Gets Funding

Synedgen Awarded National Cancer Institute Funding for Promising New Treatment for Medical Radiation-induced Bowel Injury Treatment designed to reduce pain and inflammation associated with radiation therapy to the lower bowel. Claremont, CA – September 27 – Synedgen announced today the award of a competitive Small Business Innovation Research (SBIR) Phase I contract from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to demonstrate proof-of-concept activity of Synedgen’s proprietary treatment for radiation proctitis, a condition that causes painful tissue damage to the lining of the gastrointestinal (GI) tract caused by radiotherapy. With this award, Synedgen will complete efficacy studies for its proprietary formulation of it’s polymer-based pharmaceutical, SY513, to alleviate radiation proctitis following medical radiotherapy often used to treat prostate cancer, ovarian cancer and tumors originating in the pelvic region. Radi ation proctitis impacts as much as 75% of patients treated by radiotherapy in the lower bowel area and can cause both short term and chronic pain. In some cases, acute radiation proctitis is so serious that the intensity of the radiotherapy has to be reduced, ultimately jeopardizing the patient’s prognosis for successful cancer treatment. Synedgen has developed formulations of its proprietary high molecular weight polymer therapeutics to reduce radiation or chemical damage to the oral cavity and the entire length of the GI tract. Synedgen’s orally delivered GI treatments have shown a remarkable ability to reduce local and systemic inflammation, reduce cell death and improve tissue regeneration associated with radiation-induced damage in the large and small intestines in animal models that mimic conditions seen in human therapies. “This award helps further expand our growing portfolio of oncology supportive care products. Our surface-active polymers have broad mechanism of ac tion, which are designed to reduce inflammation and tissue damage due to chemical or radiation damage. Based on our previous positive research findings, we anticipate this formulation and delivery directly to the affected area will limit the damage of radiation therapy, and allow more aggressive treatment of prostate and other pelvic cancers that are currently limited by radiation proctitis,” stated Synedgen president Shenda Baker. “Acute radiation-induced injury to the GI mucosa occurs in virtually all patients undergoing radiation therapy. Clearly, there is a need for new agents to reduce the short and long-term side effects of radiotherapy and minimize tissue damage. We are optimistic that this research will result in improved survival of and quality of life for cancer patients,” added CEO William Wiesmann M.D. This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, and Department of Health and Human Services under Contract No. HHSN261201400011C. This NCI is fully funding $196,707 for the specific project costs under the contract. About Synedgen Synedgen Inc. is an innovative biopharmaceutical company focused on developing novel therapies and products through its proprietary biomaterials technology platform. Product development is targeted to specifically address unmet needs for therapies to treat inflammation, damage or infection at dermal, pulmonary, mucosal and gastrointestinal surfaces. Synedgen’s Corporate Headquarters, Research Laboratories and Manufacturing Facility are in Claremont CA. Additional information can be found at Synedgen’s web site at Contact Information Nicole Draghic Synedgen Inc. +1 (301) 428-9818 Ext: 250

Posted in News | Comments Off on New Medical Radiation Treatment Gets Funding

Asbestos-contaminated Forest Doesn’t Burn

EPA Finds Asbestos-contaminated Libby Forest Libby, Mont – A new research says timber harvesting can effectively be used as a potential remedy for a swath of asbestos-filled Libby forest, where vermiculite mining for decades resulted in extensive pollution. The 35000 acre forest is fully contaminated and so far has escaped being burned. Asbestos-linked diseases have killed approximately 400 individuals and sickened more than 1750 people in Libby, Montana since the W.R. Grace Vermiculite mining released asbestos fibers into the air of the mountain town, which is said to be the country’s most lethal superfund site. Thus far, the United States Environmental Protection Agency (EPA) has spent around $370 M in efforts to cleanup asbestos-tainted soil and building materials from there. The Vermiculite mine, which is no longer functional, produced 2 M tons of asbestos-containing ore yearly and engaged 200 individuals when it was running in full capacity. This vermiculite was exported to countries all over the world for making insulation. Just as they pierced into the human lungs’ pleural lining, microscopic asbestos fibers also penetrated the barks of Douglas fir, lodgepole pine, larch and ponderosa in the Libby forests. A Montana University study in year 2004 measured as well as confirmed concentrations of asbestos in trees close to the Vermiculite mine site. However, the Environmental Protection Agency, which determined Libby as a dangerous Superfund site in year 2002 and made a public health emergency declaration in year 2009, had been busy with its attempts to clean up homes, schools, playgrounds and businesses. A remediation program for the contaminated forest is not in place still. It may take several years for any such efforts to begin. In the mean time, residents regularly cut logs from the forest and therefore a fire could be disastrous. In recent times, 2 remediation firms – Missoula (Mont)-based Envirocon and Po rtland (OR)-based Beck Group – won contract from the Lincoln Port Authority for drafting a feasibility research to develop a remediation program for the forest located 6 miles outside the city center of Libby. Asbestos concentrations in this site are still the highest. No evidence is there to ensure that the trees’ meat has been contaminated by the fibers of asbestos. However, according to the study reports, if harvesting as well as debarking could be attained in a safe and financially feasible manner, the sale of the timber would be profitable. Remedial measures may take 10 or more years to complete, according to the project team.

Posted in News | Comments Off on Asbestos-contaminated Forest Doesn’t Burn

Choices Made For Radiation Oncologists

Leading Radiation Oncologists Chosen to Present at Annual Conference Physicians with 21st Century Oncology, the nation’s premier cancer treatment network and largest radiation therapy provider, have been chosen to showcase their latest research developments at The American Society for Radiation Oncology (ASTRO) 56th annual meeting. San Francisco, Calif – September 10 – Several physicians with 21st Century Oncology, the nation’s premier cancer treatment network and largest radiation therapy provider, have been chosen to showcase their latest research developments at The American Society for Radiation Oncology (ASTRO) 56th annual meeting. ASTRO’s annual meeting is the premier radiation oncology scientific event that has over 11,000 attendees each year. This year, the meeting will be held from September 14-17 in San Francisco. The 21st Century Oncology physicians were given the opportunity to speak at the ASTRO meeting to share the results of comprehensive research hoping to help enhance patients’ lives. “We are excited to have such a robust presence at ASTRO this year,” says Steven Finkelstein, M.D., Board Certified Radiation Oncologist and 21st Century Oncology’s Chief Science Officer. “21st Century Oncology is conducting groundbreaking research across the nation, advancing the field of radiation oncology. We are honored to be chosen to present some of our work at this prestigious conference.” Radiation Oncologists who will be presenting their work in educational and research sessions to thousands of renowned medical professionals include: Steven Finkelstein, M.D. – Co-Director, Learning Lab; Lecturer, eContouring for Sarcoma; Moderator, scientific session regarding Immunotherapy and the Microenvironment; Discussant, ASTRO plenary session regarding radiobiology and immunotherapy Michael Ghilezan, M.D., Ph.D. – Panelist, Quality of Life Following Radiotherapy for Prostate Cancer; Educational Session, Interst itial Brachytherapy for Prostate Cancer Tyler Hollen, M.D. – Oral presentation, HPV and Squamous Cell Carcinoma of the Oropharynx Teamour Nurushev, Ph.D. – Educational Session, Stereotactic Body Radiation Therapy Gustavo Olivera, Ph.D. – Oral presentation, Data Analysis of Radiation Oncology Patient Registries Frank Vicini, M.D. – Lecturer, Learning Lab eContouring for Breast Cancer; Panelist, Clinical Trials in Breast Cancer Radiotherapy Physicians and physicists who have presentations at ASTRO include: Christopher Chen, M.D. Elisa E. Córdoba Eduardo Fernandez, M.D., Ph.D. Gustavo Ferraris, M.D. Steven Finkelstein, M.D. Evan Landau, M.D. Constantine Mantz, M.D. James Marsh, M.D. Niraj Mehta, M.D. Xiaohu Mo, M.S. Gustavo Olivera, Ph.D. Jesse Schulman In addition, Eduardo Fernandez, M.D., Ph.D. – Board Certified Radiation Oncologist in Plantation, Florida, and 21st Century Oncology’s Senior Vice President of Medical Affairs – will be accepting the esteemed distinction of being named a Fellow of ASTRO. This is one of the highest honors in the profession, created to recognize outstanding physicians for their leadership role in radiation oncology. “One of the founding principles of our company is our commitment to advancing the field of radiation therapy through research,” says Daniel Dosoretz, M.D., CEO and co-founder of 21st Century Oncology. “Our strong presence at ASTRO demonstrates our commitment to remain the leading radiation oncology provider in the nation.” For more information about our services, visit About 21st Century Oncology: 21st Century Oncology is the largest global, physician led provider of Integrated Cancer Care services. The company offers a comprehensive range of cancer treatment services, focused on delivering academic quality, cost-effective patient care in personal and convenient settings. The company operat es 185 treatment centers, including 150 centers located in 16 states. The company also operates 35 centers located in six countries in Latin America. The company holds market-leading positions in most of its domestic local markets and abroad. Contact Information Melissa Rogovin FULL CIRCLE PR +1 (813) 887-3277 Ext: 104

Posted in News | Comments Off on Choices Made For Radiation Oncologists

Downtown Steam Pipe Rupture Releases Asbestos Fibers

An underground 14-inch steam pipe ruptured close to Boston City Hall this morning, releasing steam as well as low levels of asbestos fibers into the surroundings, the fire department in Boston informed. The leak occurred just after 1 AM on Congress St at Hanover St, department spokesperson Steve MacDonald said. When the pipe busted, it released steam and asbestos particles into the surroundings, MacDonald said. Asbestos had been used for insulating the pipe. “We are not very sure yet what exactly caused the rupture. It is a very rare episode,” Rowan Sanders, the spokesperson representing Veolia Energy, said in a statement. Veolia Energy is the steam utility, which operates the pipeline. Steam was pushed through the busted pipe that is buried beneath the ground under a concrete layer. The incident created confusion in the streets, said Sanders. Utility officials have hired an abatement company for dealing with asbestos that is sprayed all through the heaps of ruptured concrete and dirt, said Sanders He said asbestos material was a commonly used material, and it was especially used for insulating purpose. He said crews are going to replace the dangerous material with mineral wool when they get access to that pipe. “We must clean up the asbestos and have the material hauled away by authorized professionals. We’ve to clean up all the dust that can be seen and ensure that it is safely disposed of,” Sanders said. The leak was covered by the steam utility with a provisional plate. Plans for digging up the street and completely repair that pipe once a specific time could be fixed with the city officials, Sanders said. A portion of Congress St has been shut for cleanup works. It will be reopened shortly. “We are doing regular testing for ensuring that the public is absolutely safe. The air quality tests came back okay,” Sanders said. If asbestos fibers are breathed in, it can cause fatal diseases including cancer. The broken pipe didn’t cause any serious injuries or service disruptions to the customers. However, the company expects to find out the reason for preventing it from occurring again “You have to study the actual cause of the incident so that you will be able to figure out what is taking place and how can you prevent it. We regret any inconvenience caused to any pedestrian or vehicular traffic,” Sanders said.

Posted in News | Comments Off on Downtown Steam Pipe Rupture Releases Asbestos Fibers

Volunteers Needed For Water Station

Volunteers Needed to Staff Mile 19 Water Station at NYC Marathon The Mesothelioma Applied Research Foundation (Meso Foundation) is recruiting volunteers to staff its official Mile 19 water stop at the New York City Marathon. Alexandria, VA – June 27 – This year, the Mesothelioma Applied Research Foundation (Meso Foundation) has received the opportunity to staff the official water stop at Mile 19 of the New York City Marathon. The Meso Foundation is now recruiting volunteers interested in working on marathon day, on Sunday, November 2, between the hours of 7:30 AM – 3:30 PM. Due to planning and security concerns, all interested volunteers must register online by July 31, 2014. No walk-ins are allowed. The New York City Marathon is an event featuring over 50,000 runners and over 2 million spectators. The registration process is outlined on Meso Foundation’s blog. Any questions about volunteering at the New York City Marathon can be directed to dpurcell (at)curemeso(dot)org. Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. Medical experts consider it one of the most aggressive and deadly of all cancers. An estimated one-third of those who develop mesothelioma were exposed while serving in the Navy or working in shipyards. About the Mesothelioma Applied Research Foundation The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively seeks philanthropic support to fund peer-reviewed mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer reviewed scientific research to establish effective treatments for mesothelioma and, ultimately, a cure for this extremely aggres sive cancer. To date, the Foundation has awarded over $8.7 million to research. More information is available at Contact Information Maja Belamaric Mesothelioma Applied Research Foundation +1 7038793822

Posted in News | Comments Off on Volunteers Needed For Water Station

Researchers Study: No Apnea / Cancer Link

Dental Sleep Apnea Appliances Have Advantages Over Traditional Solutions, Woodland Hills Dental Expert Says A study by Canadian researchers released earlier this month found no evidence linking obstructive sleep apnea with cancer. As this report is likely to increase public awareness and discussion of sleep apnea, prosthodontist Dr. Saj Jivraj of the Anacapa Dental Art Institute in Ventura County, Calif., is urging members of the media and the public to look beyond surgery and Continuous Positive Airway Pressure (CPAP) as the only remedies for sleep apnea. Woodland Hills, CA – August 26 – A study by Canadian researchers released Aug. 5 in the Canadian Medical Association Journal found no evidence linking obstructive sleep apnea with cancer. As this report is likely to increase public awareness and discussion of sleep apnea, prosthodontist Dr. Saj Jivraj of the Anacapa Dental Art Institute in Ventura County, Calif., is urging members of the media and the pub lic to look beyond surgery and Continuous Positive Airway Pressure (CPAP) as the only remedies for sleep apnea. There is a common, non-surgical solution that highly trained dentists use to treat the condition – Oral Appliance Therapy. CPAP still is considered the “standard” treatment by many physicians, but with usage rates reportedly less than 50 percent, many patients would be better served using a proven, alternative therapy, Dr. Jivraj said. “The Academy of Sleep Medicine (AASM) guidelines say that patients with mild or moderate sleep apnea should be given a choice between a CPAP machine or an oral appliance,” Dr. Jivraj said. “Patients deserve to be told of all their sleep apnea treatment options, including Oral Appliance Therapy.” While many people associate Dr. Jivraj and his partner, Dr. Mamaly Reshad, with their Woodland Hills cosmetic dentistry services, the Anacapa Dental Art Institute can provide patients with an oral appliance to address their sle ep apnea. The oral appliance created to treat sleep apnea usually consists of custom-made, removable upper and lower trays that fit over the patient’s teeth. A mechanism connects the upper and lower trays and holds the wearers’ jaw forward while he or she sleeps. By holding the jaw forward, the oral appliance moves the tongue forward and keeps it from blocking the airway during sleep, which is what occurs in sleep apnea. Prosthodontists like Dr. Jivraj and Dr. Reshad have advanced dental training about oral health conditions, including sleep apnea, and specialize in fitting and finding the correct position to treat mild to moderate cases of sleep apnea without surgery or CPAP. Dr. Jivraj and Dr. Reshad are award-winning prosthodontists. They are specialists in implant, cosmetic and reconstructive dentistry. Both are former chairmen of the University of Southern California School of Dentistry’s Fixed Prosthodontics and Operative Dentistry section. They also are intern ational lecturers and published authors. Dr. Jivraj earned his degree at the University of Manchester in his native England. He received advanced prosthodontic training at the USC School of Dentistry. He has published numerous articles on aesthetic and implant dentistry in peer-reviewed journals, and has presented on implant dentistry and advanced prosthodontic procedures nationally and internationally. Dr. Jivraj is co-author of the textbook “Treatment Planning in Implant Dentistry,” which is used around the world. He is on the editorial board of the highly prestigious Journal of Esthetic and Restorative Dentistry, ad hoc reviewer for the Journal of Prosthetic Dentistry and is associate clinical editor for Dental Teamwork magazine. He currently holds a faculty position as an associate clinical professor at the USC School of Dentistry, clinical teacher at the Eastman Dental Institute in London and is on the board of directors for the British Academy of Restorative Den tistry. Jivraj was voted “Best of USA” by his peers in 2008. Dr. Reshad, a fellow prosthodontist, is an internationally known expert in restorative and cosmetic dental procedures. He has published in numerous peer-reviewed journals and textbooks on various topics related to prosthodontics, aesthetics and implant dentistry. Dr. Reshad trained at Kings College Dental School followed by the Eastman Dental Institute in London. Dr. Reshad is on the editorial board for the Journal of Esthetic and Restorative Dentistry. He is an honorary clinical teacher at the Eastman Dental Institute and a member of the faculty of the Global Institute for Dental Education. The Anacapa Dental Art Institute has been offering quality dental care treatments since 1996. The team specializes in implant, prosthodontic, cosmetic and restorative dentistry. It also offers gentle dental care treatments for patients aged 50 and above. The Anacapa Dental Art Institute has two new sta te-of-the-art training and dental offices in Oxnard and Woodland Hills, Calif., respectively. The Oxnard location, at 2821 North Ventura Road, Bldg H, has 3,600 square feet encompassing six treatment rooms, a fully in-house dental lab and a state-of-the-art teaching center, according to Anacapa Dental Art Institute founder Dr. Saj Jivraj. The on-site teaching center includes a high-tech suite where other dentists can observe patient treatments. Courses have been arranged for dentists from Japan, China, India and South America. The Woodland Hills office, at 6325 Topanga Canyon Boulevard, No. 513, is 1,500 square feet and it features an in-house dental lab catering to patients in and around Los Angeles. The Anacapa Dental Art Institute has a staff of 11, which includes the two prosthodontists, a root canal specialist, a general dentist, two hygienists, three dental assistants and two receptionists. The Anacapa Dental Art Institute provides the following procedures: ? All-on -4 dental implants ? All on Six (All on 6) dental implants ? Mini dental implants ? New smile in a day ? Teeth in an Hour ? Full mouth reconstruction ? Teeth whitening ? Invisalign teeth straightening ? Sedation dentistry ? Cosmetic dentures (“facelift”) Those looking for a Thousand Oaks dentist or Ventura affordable cosmetic dentistry can get more information about Dr. Jivraj and Dr. Reshad at or call the Oxnard office at (805) 604-5811 or the Woodland Hills office at (818) 839-7419. Contact Information Saj Jivraj Anacapa Dental Art Institute +1 (805) 604-5811

Posted in News | Comments Off on Researchers Study: No Apnea / Cancer Link

Compound Sensitizes Mesothelioma Cells

New Research Finds Compound Sensitizes Mesothelioma Cells to Tumor-Fighting Drugs, According to Surviving Mesothelioma Italian researchers say a treatment made from a human protein can help improve the effectiveness of chemotherapy for patients fighting malignant pleural mesothelioma. Raleigh, NC – June 20 – A team of cancer doctors says the combination of a lab-created compound based on a human protein and traditional chemotherapy drugs can help shrink mesothelioma tumors better than either treatment alone. Surviving Mesothelioma has just posted an article on the new research. Doctors with the University of Padua and the Instituto Oncologico Veneto in Padua have found that a version of TNL-related apoptosis-inducing ligand (TRAIL), a protein produced by healthy tissues, can trigger the destruction of mesothelioma cells when combined with carboplatin and pemetrexed (CP). Researchers referred to the TRAIL compound as ‘T’. “Results demonstrated a sign ificant increase of apoptosis in cell lines treated with CPT compared with those receiving CP or T as single agents,” reports medical oncologist, Guilia Pasello, MD, the study’s primary author. In their new report in the Journal of Thoracic Oncology, the researchers hypothesize that the chemotherapy drugs may make mesothelioma cells more sensitive to TRAIL’s cell death signals. The cell-destroying effect of the CPT combination worked on mesothelioma cells lines in the lab, as well as in live mice. “Although most mesothelioma patientswill have chemotherapy at some point during treatment, it has only limited effectiveness,” says Surviving Mesothelioma’s Managing Editor, Alex Strauss. “If another compound could help these drugs work better, it could potentially improve outcomes for thousands of mesothelioma patients every year.” For a more complete explanation of how the CPT combination is thought to work, see Combination Treatment Fights Mesothelioma “Syne rgistically”, now available on the Surviving Mesothelioma website. Source: Pasello, G. et al., “Synergistic Antitumor Activity of Recombinant Human Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Combination with Carboplatin and Pemetrexed in Malignant Pleural Mesothelioma.” For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis, and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions. Contact Information Michael Ellis Cancer Monthly +1 (919) 570-8595

Posted in News | Comments Off on Compound Sensitizes Mesothelioma Cells

County to Remove Asbestos

County to Remove Asbestos from the Mexico DSS Building

Pulaski – Oswego County has decided to hire Tetra Tech Architects & Engineers for an asbestos abatement project. Asbestos-containing tiles at the Mexico DSS (Department of Social Service) building will be removed. The decision was approved by the legislators on Thursday. They have also increased the capital funding for the asbestos abatement project from US$30000 to 100000.
The initial asbestos survey and the agreement with the abatement contractor will be covered by the US$100,000. The cancer-causing mineral was originally found in the Mexico DSS building in early 2012, after a staff member asked Oswego County whether they had ever tested the tiles.
The levels of asbestos are somewhat higher than the federally accepted levels, said Phil Church, the administrator. Air sampling tests indicated that t he region was absolutely safe for working. However, each time the tiles were shifted for accessing cables, telephone cables, and environmental management systems, the risk of asbestos fibers to become airborne increased. When it becomes airborne, asbestos can be dangerous. Whoever inhale those tiny fibers are at risk of developing fatal asbestos-related diseases including lung cancer, asbestosis and mesothelioma. Asbestos is not so dangerous as long as it remains stable. Release of asbestos fibers into the air and subsequent dangers occur only when the material is broken or disturbed.
Congressmen will finally say regarding the amount spent on the asbestos abatement. However, alterations inside the structure can also be a part of the abatement project. Officials said on Thursday that the county will be reimbursed 75% of the abatement expenses by the state.
Though the county has taken a decision on asbestos abateme nt project, it has many other decisions that are still pending. Tetra Tech will invite bids for sub-contracting. The bids are supposed to reach in September.
The complete expense of the asbestos abatement will be known only after seeing the bids. However, Church guesses the expense could be between $600,000 and $800,000.
Because of worries that the asbestos removal and remodeling could cost $1 million, Congressperson Louella LeClair voted against the decrees in a meeting of the Finance & Personal and the Infrastructure & Facilities committees. However, later she supported the resolution once it has been explained that the legislators will have the last say.
I feel it is really important that the asbestos is removed. No doubt, that must be done. The other issues should be watched more closely,” Louella LeClair said.

Posted in News | Comments Off on County to Remove Asbestos

Asbestos Lawsuit Names Companies

Charleston – A Melbourne (FL) couple has filed a lawsuit against 39 corporations that are allegedly liable for a mesothelioma diagnosis. The lawsuit was filed by Barbara Amick and her husband Eldon Amick in Kanawha Circuit Court on April 20. The suit says Barbara Amick was diagnosed with mesothelioma on December 13, 2011. The plaintiffs say the defendant companies are responsible for the mesothelioma diagnosis as they exposed Barbara Amick to asbestos which is why she developed the malignant disease. Barbara Amick was employed in sales and accounts departments from 1952 to 1977, the complaint says. Barbara Amick says she was also exposed to the cancer-causing material during renovations at her husband’s Vienna home between 1950 and 1970. The plaintiffs are asking for punitive and compensatory damages.

Posted in News | Comments Off on Asbestos Lawsuit Names Companies